Aushon Biosystems Appoints Bill Williams Vice President of Sales
Published: Nov 01, 2012
BILLERICA, Mass., Nov. 1, 2012 /PRNewswire/ -- Aushon BioSystems today announced that Bill Williams, Ph.D. has been appointed Vice President of Sales, effective immediately. Dr. Williams will report to Martin Verhoef, Chief Executive Officer of Aushon BioSystems.
"We are very pleased that we have been able to attract a talented sales executive the caliber of Dr. Williams. His track record and strategic insight in product commercialization in the academic and pharmaceutical life sciences markets are truly excellent. Aushon has achieved its product development milestones and has already seen very good market acceptance of its products. Dr. Williams is an essential complement to the leadership team to help the company succeed in achieving its commercial milestones," commented Martin Verhoef, CEO.
"I'm very excited to assume my role at Aushon BioSystems. The company is poised for success and my background in capital goods selling and sales processes in general will help establish a platform for growth," Dr. Williams said.
Bill A. Williams, Ph.D. has 15 years of progressive sales and marketing experience in the life science industry, providing strategic planning and implementation of direct sales prospecting activities and out-bound marketing campaigns. Prior to joining Aushon, he was the founder and owner of life science market research company, Web Prospects, providing global, in-depth prospect analysis for life science tools and service providers where he grew the business to include over 70 client companies with interests spanning the continuum of research and diagnostics. Bill also previously held the position of US National Sales Manager for Ciphergen Biosystems, responsible for a 40-member sales, applications support, and service engineering team. Bill started his sales career as a Technology Sales Consultant for Beckman Coulter. He holds a B.S. in Chemistry from Angelo State University and a Ph.D. in Analytical Chemistry from Texas A&M University.
For more information on the Cira platform visit: www.aushon.com.
Aushon BioSystems, Inc., provides a comprehensive suite of multiplex immunoassay products and services for protein biomarker discovery, development, and analysis to leading pharmaceutical, biotechnology, academic, and diagnostic clients worldwide. Our unique combination of proprietary microarray printing, extensive biomarker content, and our innovative Cira immunoassay platform deliver exceptional performance, quality, and reliability to accelerate preclinical and clinical biomarker research. Our customers, who include nine of the top ten pharmaceutical companies, trust Aushon to supply the most reliable biomarker data available, lowering costs and improving research productivity.
SOURCE Aushon BioSystems